{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Trial highlights from EACTS Annual Meeting 2023","description":"Join our hosts Can Gollmann-Tepek\u00f6yl\u00fc and Miia L Lehtinen for their late-breaking trials highlights presented at the 37th EACTS Annual Meeting in Vienna, including:&amp;nbsp;  (2:40 - 8:53)&amp;nbsp;Subannular Repair for Secondary Mitral Regurgitation with restricted systolic leaflet Motion (type IIIb): 2-year results from REFORM-MR registry&amp;nbsp;by Dr Jonas Pausch&amp;nbsp;&amp;nbsp; (8.53 - 13:47)&amp;nbsp;Mechanistic insights from the CAST-HF trial: Transcriptomic analysis of human myocardial biopsies reveal biglycan as crucial mediator of angiogenesis&amp;nbsp;by Dr Johannes Holfeld&amp;nbsp;&amp;nbsp; (13.47 - 20:55)&amp;nbsp;First-in-human experience with a novel custom-made double branch stent graft for aortic arch repair \u2013 The NEXUS DUO by Prof Mario Louis Lachat &amp;amp; Dr P Buyl&amp;nbsp;&amp;nbsp; (20:56 - 25:28)&amp;nbsp;Real World Experience of 510 On-X Aortic Valve Replacement Patients Treated with Low Dose Warfarin&amp;nbsp;by Prof Aungye OO&amp;nbsp;&amp;nbsp; (25:28 - 32:1)&amp;nbsp;CEASE-AF: Effectiveness and safety of hybrid epicardial and endocardial ablation in patients with persistent and longstanding persistent atrial fibrillation by Dr Piotr Suwalski.  ","author_name":"A Cut Above: Cardiothoracic insights from EACTS","author_url":"https:\/\/www.eacts.org\/publications\/a-cut-above-podcast\/","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/28806708\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/item\/28806708"}